EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival

DSpace Repository

Show simple item record

dc.contributor.author Spengler, Werner
dc.date.accessioned 2013-12-09T10:01:04Z
dc.date.available 2013-12-09T10:01:04Z
dc.date.issued 2013
dc.identifier.issn 0169-5002
dc.identifier.uri http://hdl.handle.net/10900/39141
dc.language.iso en en
dc.publisher Elsevier Ireland Ltd de_DE
dc.relation.uri http://dx.doi.org/10.1016/j.lungcan.2013.02.010 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival de_DE
dc.type Article de_DE
utue.quellen.id 20130911224530_00644 de_DE
utue.publikation.seiten 306-312 de_DE
utue.personen.roh Faehling, M.
utue.personen.roh Eckert, R.
utue.personen.roh Kamp, T.
utue.personen.roh Kuom, S.
utue.personen.roh Griese, U.
utue.personen.roh Straeter, J.
utue.personen.roh Ott, G.
utue.personen.roh Spengler, W.
dcterms.isPartOf.ZSTitelID Lung Cancer de_DE
dcterms.isPartOf.ZS-Issue 3 de_DE
dcterms.isPartOf.ZS-Volume 80 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record